This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Samyang Corporation. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Innovations of Han-Uk Kong in Drug Delivery Systems.
Introduction
Han-Uk Kong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on amphiphilic block copolymers. His research focuses on enhancing the efficacy and stability of drug carriers, which is crucial for improving therapeutic outcomes.
Latest Patents
One of Han-Uk Kong's notable patents is titled "Negatively charged amphiphilic block copolymer as drug carrier." This invention provides an anionic group-containing amphiphilic block copolymer that is both biocompatible and biodegradable. When utilized as a drug carrier for cationic drugs, it offers several advantages, including increased blood concentration and improved stability of the drug. This patent highlights his commitment to advancing medical technology and improving patient care.
Career Highlights
Han-Uk Kong is associated with Samyang Corporation, where he continues to innovate and develop new solutions in the pharmaceutical industry. His work has garnered attention for its potential to revolutionize drug delivery methods, making treatments more effective and safer for patients.
Collaborations
He collaborates with talented colleagues such as Min-Hyo Seo and In-Ja Choi, who contribute to his research endeavors. Their combined expertise enhances the development of innovative solutions in drug delivery systems.
Conclusion
Han-Uk Kong's contributions to the field of drug delivery through his patented innovations demonstrate his dedication to improving healthcare. His work not only advances scientific knowledge but also has the potential to significantly impact patient treatment outcomes.